Adipose Inflammation and Diabetes (FAB)

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

18 participants

Study Classification

OBSERVATIONAL

Study Start Date

2019-08-01

Study Completion Date

2027-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The study investigates whether the addition of resolution molecules can inhibit inflammation and insulin resistance in human tissue taken from obese individuals, and whether the results of these studies correlate with patient-specific resolution phenotypes.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

NEFA (Non Esterified Fatty Acid) , Adipose Factors Behind Insulin Sensitivity

NCT01727245

Obesity Non-obese Controls

COMPLETED NA

Adipose Tissue Expandability and Type 2 Diabetes

NCT03155412

Type2 Diabetes Mellitus

COMPLETED

Does Class of Dietary Fat Affect Insulin Resistance?

NCT01541592

Insulin Resistance

COMPLETED NA

Acute Effects of an Oral Fat Load on Skeletal Muscle and Hepatic Insulin Sensitivity

NCT01736202

Insulin Sensitivity

COMPLETED PHASE4

Postprandial Fatty Acid Metabolism in the Natural History of Type 2 Diabetes (T2D)

NCT02808182

Impaired Glucose Tolerance

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Obese

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Study patients

Obese subjects scheduled to undergo abdominoplasty surgery are included. These are later classified according to metabolic status.

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* BMI 30-40 kg/m2
* Ptos (i.e. excess skin) \> 3 cm
* Patient underwent gastric bypass surgery \>2 years ago
* Patient has had a stable weight ≥6 months at the time of operation
* Patient does not smoke (min 6 weeks prior to surgery)

Exclusion Criteria

* Patients who do not understand spoken and written Swedish
* American Society of Anesthesiologists (ASA) classification ≥ 3
* Neurological, orthopedic or rheumatologic injury or illness affecting physical ability
* Preoperatively known hernia requiring surgical operation
* Severe mental illness

Minimum Eligible Age

18 Years

Maximum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No